339 related articles for article (PubMed ID: 23586059)
1. Mass spectrometry-based proteomics in molecular diagnostics: discovery of cancer biomarkers using tissue culture.
Paul D; Kumar A; Gajbhiye A; Santra MK; Srikanth R
Biomed Res Int; 2013; 2013():783131. PubMed ID: 23586059
[TBL] [Abstract][Full Text] [Related]
2. Proteomic Approaches for Biomarker Panels in Cancer.
Tanase C; Albulescu R; Neagu M
J Immunoassay Immunochem; 2016; 37(1):1-15. PubMed ID: 26565430
[TBL] [Abstract][Full Text] [Related]
3. Quantitative proteomics for cancer biomarker discovery.
Liang S; Xu Z; Xu X; Zhao X; Huang C; Wei Y
Comb Chem High Throughput Screen; 2012 Mar; 15(3):221-31. PubMed ID: 22221055
[TBL] [Abstract][Full Text] [Related]
4. Profiling signatures of ovarian cancer tumour suppression using 2D-DIGE and 2D-LC-MS/MS with tandem mass tagging.
Sinclair J; Metodieva G; Dafou D; Gayther SA; Timms JF
J Proteomics; 2011 Apr; 74(4):451-65. PubMed ID: 21237297
[TBL] [Abstract][Full Text] [Related]
5. Proteomics for discovery of candidate colorectal cancer biomarkers.
Alvarez-Chaver P; Otero-Estévez O; Páez de la Cadena M; Rodríguez-Berrocal FJ; Martínez-Zorzano VS
World J Gastroenterol; 2014 Apr; 20(14):3804-24. PubMed ID: 24744574
[TBL] [Abstract][Full Text] [Related]
6. Proteomics in diagnosis of prostate cancer.
Davalieva K; Polenakovic M
Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2015; 36(1):5-36. PubMed ID: 26076772
[TBL] [Abstract][Full Text] [Related]
7. Application of proteomics in cancer gene profiling: two-dimensional difference in gel electrophoresis (2D-DIGE).
Hariharan D; Weeks ME; Crnogorac-Jurcevic T
Methods Mol Biol; 2010; 576():197-211. PubMed ID: 19882264
[TBL] [Abstract][Full Text] [Related]
8. The ongoing evolution of proteomics in malignancy.
Dhamoon AS; Kohn EC; Azad NS
Drug Discov Today; 2007 Sep; 12(17-18):700-8. PubMed ID: 17826682
[TBL] [Abstract][Full Text] [Related]
9. Proteomics and cancer diagnosis: the potential of mass spectrometry.
Rodland KD
Clin Biochem; 2004 Jul; 37(7):579-83. PubMed ID: 15234239
[TBL] [Abstract][Full Text] [Related]
10. Proteomic biomarkers in lung cancer.
Pastor MD; Nogal A; Molina-Pinelo S; Carnero A; Paz-Ares L
Clin Transl Oncol; 2013 Sep; 15(9):671-82. PubMed ID: 23606351
[TBL] [Abstract][Full Text] [Related]
11. Mass spectrometry-assisted gel-based proteomics in cancer biomarker discovery: approaches and application.
Huang R; Chen Z; He L; He N; Xi Z; Li Z; Deng Y; Zeng X
Theranostics; 2017; 7(14):3559-3572. PubMed ID: 28912895
[TBL] [Abstract][Full Text] [Related]
12. Breast cancer biomarkers: proteomic discovery and translation to clinically relevant assays.
Chung L; Baxter RC
Expert Rev Proteomics; 2012 Dec; 9(6):599-614. PubMed ID: 23256671
[TBL] [Abstract][Full Text] [Related]
13. Quantitative proteomic analysis of microdissected oral epithelium for cancer biomarker discovery.
Xiao H; Langerman A; Zhang Y; Khalid O; Hu S; Cao CX; Lingen MW; Wong DTW
Oral Oncol; 2015 Nov; 51(11):1011-1019. PubMed ID: 26321370
[TBL] [Abstract][Full Text] [Related]
14. Cancer biomarker development and two-dimensional difference gel electrophoresis (2D-DIGE).
Kondo T
Biochim Biophys Acta Proteins Proteom; 2019 Jan; 1867(1):2-8. PubMed ID: 30392560
[TBL] [Abstract][Full Text] [Related]
15. An integrated cell line-based discovery strategy identified follistatin and kallikrein 6 as serum biomarker candidates of breast carcinoma.
Mangé A; Dimitrakopoulos L; Soosaipillai A; Coopman P; Diamandis EP; Solassol J
J Proteomics; 2016 Jun; 142():114-21. PubMed ID: 27168011
[TBL] [Abstract][Full Text] [Related]
16. Tissue culture-based breast cancer biomarker discovery platform.
Kulasingam V; Diamandis EP
Int J Cancer; 2008 Nov; 123(9):2007-12. PubMed ID: 18712711
[TBL] [Abstract][Full Text] [Related]
17. Proteomics in colorectal cancer translational research: biomarker discovery for clinical applications.
de Wit M; Fijneman RJ; Verheul HM; Meijer GA; Jimenez CR
Clin Biochem; 2013 Apr; 46(6):466-79. PubMed ID: 23159294
[TBL] [Abstract][Full Text] [Related]
18. Clinical Perspective on Proteomic and Glycomic Biomarkers for Diagnosis, Prognosis, and Prediction of Pancreatic Cancer.
Hanna-Sawires RG; Schiphuis JH; Wuhrer M; Vasen HFA; van Leerdam ME; Bonsing BA; Mesker WE; van der Burgt YEM; Tollenaar RAEM
Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33800786
[TBL] [Abstract][Full Text] [Related]
19. Clinical proteomics in cancer: Where we are.
Panis C; Pizzatti L; Souza GF; Abdelhay E
Cancer Lett; 2016 Nov; 382(2):231-239. PubMed ID: 27561426
[TBL] [Abstract][Full Text] [Related]
20. Integrative analysis to select cancer candidate biomarkers to targeted validation.
Kawahara R; Meirelles GV; Heberle H; Domingues RR; Granato DC; Yokoo S; Canevarolo RR; Winck FV; Ribeiro AC; Brandão TB; Filgueiras PR; Cruz KS; Barbuto JA; Poppi RJ; Minghim R; Telles GP; Fonseca FP; Fox JW; Santos-Silva AR; Coletta RD; Sherman NE; Paes Leme AF
Oncotarget; 2015 Dec; 6(41):43635-52. PubMed ID: 26540631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
